comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-30 17:44:01 - browse：31887

UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures.

The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing. Initially, after a mid-February cyberattack took its system offline, hampering insurers’ ability to receive claims and send payments, UnitedHealth offered loans to bridge the gap while the company worked to fix the outage, but many providers said it didn’t accomplish that.

It’s not clear exactly what prompted the change in these providers’ offers, or how broadly it applies. The new offers came just days after UnitedHealth officials met virtually with Health and Human Services Secretary Xavier Becerra and other White House officials. At that meeting, HHS said it explicitly asked UnitedHealth to send advance payments to providers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Physicians and social media: If you see something, say something?

WSS

Why palliative psychiatry is worth discussing

Alabama hospital puts IVF treatments on hold

5 to watch: Tech startups trying to solve health care's staffing crisis

The Harvard botanist who searched for psychedelics in the Amazon

5 to watch: Tech startups trying to solve health care's staffing crisis

New documents shed light on MD Anderson Cancer Institute feud

hotspot

comprehensive

entertainment

Moonlake's readout produced a cash windfall. Risks remain

UnitedHealth increases loan offers after Change Healthcare outage

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

After affirmative action ruling, medical educators look to 'holistic review'

Dario to buy mental health app maker Twill in cash and stock deal

In age of alternative facts, a scholarly course on calling out crap

Creating egg and sperm cells from stem cells raises ethical issues

leisure time

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Physicians and social media: If you see something, say something?

Antivenom research: Lessons from HIV applied in search for universal antidote

Virtual Event: March of the Biosimilars

NIH study of ME/CFS points to clear biological hallmarks

Health AI adoption puts security, privacy startups on investors' radar

focus

focus

explore

entertainment